Who Owns TRDA?

Entrada Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$12.97

+0.34 (+2.65%)

Market Cap

$483.5M

Shares Outstanding

38,284,313

Institutional Holders

109

Total Inst. Value

$267.0M

% of Float Held

182.4%

QoQ Holder Change

+46

Institutional data as of Q1 2025

New Positions

21

Closed Positions

12

Increased

26

Decreased

42

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BAKER BROS. ADVISORS LP$44.0M4,865,819
25AM Venture Management, LLC$39.9M4,408,379
3MPM ASSET MANAGEMENT LLC$39.6M4,381,062
4PRICE T ROWE ASSOCIATES INC /MD/$24.7M2,736,767
5BlackRock, Inc.$18.0M1,990,853
6Merck & Co., Inc.$15.7M1,739,768
7VANGUARD GROUP INC$14.2M1,575,594
8FMR LLC$11.2M1,239,811
9WELLINGTON MANAGEMENT GROUP LLP$9.5M1,053,314
10StepStone Group LP$6.9M761,277

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold TRDA?

As of Q1 2025, 109 institutional investors report holding TRDA (Entrada Therapeutics, Inc.) in their 13F filings.

What percentage of Entrada Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 182.4% of Entrada Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most TRDA?

The largest institutional holder of TRDA is BAKER BROS. ADVISORS LP with $44.0M in shares.

Are institutions buying or selling TRDA?

This quarter, 21 institutions opened new positions in TRDA and 12 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.